HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Partnership to develop an AIDS vaccine using a promising new technology

GlaxoSmithKline Biologicals (GSK Biologicals) and the International AIDS Vaccine Initiative (IAVI) today announced a public-private partnership to develop an AIDS vaccine using a promising new technology.

21 Jun 2005

Inexpensive tests can be used to decide who needs HIV treatment in poor countries

Researchers from the Johns Hopkins Bloomberg School of Public Health, Centers for Disease Control and Prevention and the Chiang Mai University in Thailand, evaluated the ability of inexpensive biological markers, which are obtainable in resource-poor countries, to determine which HIV-infected patients are in the greatest need of antiretroviral therapy.

20 Jun 2005

BMA calls on government to tackle healthcare skills drain at G8

The G8 nations must address the exodus of healthcare workers from the developing world if they are to tackle global poverty, the British Medical Association and the Royal College of Nursing tell the government today (Friday 17 June, 2005).

16 Jun 2005

Dental care needs for HIV patients continue to rise

People with HIV now are living longer and the number of dental patients treated monthly at the Oregon Health & Science University School of Dentistry's Russell Street Clinic continues to grow.

16 Jun 2005

Tentative approval for Lamivudine tablets

The U.S. Food and Drug Administration (FDA) has announced the tentative approval of Lamivudine Tablets manufactured by Aurobindo Pharma LTD. Hyderabad, India.

16 Jun 2005

Vical receives $12 Million HIV vaccine order

Vical Incorporated announced today the receipt of approximately $12.1 million in production orders for multiple clinical lots of DNA vaccines against HIV for the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, under a subcontract managed by SAIC-Frederick, Inc.

16 Jun 2005

Risky sexual behaviour fuelled in gay and bisexual men by the internet

A U.S. study says that gay and bisexual men who use the internet to meet partners are apparently more likely to engage in risky sex but tend to do so with people who have the same HIV status.

16 Jun 2005

Dartmouth Medical School collaboration in Tanzania may alter assumptions about the diagnosis of tuberculosis in HIV-infected people

New findings from a Dartmouth Medical School collaboration in Tanzania may alter assumptions about the diagnosis of tuberculosis in HIV-infected people, and prompt a major change in way TB testing is routinely done in the developing world.

15 Jun 2005

New Zealand moves to routinely offering antenatal HIV screening

New Zealand will progressively move to a policy of routinely offering antenatal HIV screening as part of antenatal care, Ministry of Health spokesman Dr Pat Tuohy said this week.

15 Jun 2005

Promising new tuberculosis drug enters clinical trial

A promising new drug candidate that may be effective against both actively dividing and slow-growing Mycobacterium tuberculosis (M. tb) has begun testing in humans, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced this week.

15 Jun 2005

President Bush's cut to AIDS prevention in Africa would be devastating

President Bush claims to have tripled US aid to Africa, yet he has set the Global Fund on a course to disaster. While promising to back the Fund, the cut he has proposed to the US contribution to the Fund could lead to a massive reduction in HIV/AIDS prevention and care for orphans.

14 Jun 2005

'Hazardous' drinking and drug use are much less severe but much more common than dependence

Research has found that individuals with alcohol and drug dependencies have a greater occurrence of injuries, hypertension, HIV, hepatitis, acid-related peptic disorders, liver cirrhosis, depression, anxiety disorders, and major psychoses.

14 Jun 2005

Non-profit public-private partnership develops affordable, new drug regimens for tuberculosis

The Global Alliance for TB Drug Development (TB Alliance), a non-profit public-private partnership developing affordable, new drug regimens for tuberculosis, today announced the start of Phase I clinical trials for the lead TB drug in its pipeline, PA-824. The trials begin this month.

14 Jun 2005

A million Americans now living with the AIDS virus and blacks account for 47 percent of HIV cases

According to the U.S. Government more than a million Americans are currently living with the AIDS virus.

14 Jun 2005

China legislates to curb discrimination against HIV/AIDS

China, where discrimination against those suffering from the AIDS virus is rife, now has a new law which aims to protect people infected with the virus.

13 Jun 2005

Optimists don't always fare better than pessimists in their immunologic response to stress

The difference seems to be based on the degree of stress facing the optimist and the degree to which a pessimist avoids the problem, according to an article in the current issue of the journal Brain, Behavior, and Immunity by Suzanne Segerstrom, Ph.D., of the University of Kentucky.

10 Jun 2005

South Africa still debating how to tackle HIV/AIDS when 5 million are infected

A national conference in South Africa was dominated this week by the continuing debate over HIV/AIDS drugs.

10 Jun 2005

AIDS expert says global strategy needed to combat feminization of HIV/AIDS

Thomas C. Quinn, M.D., a Johns Hopkins physician and scientist, who has spent the best part of the last 25 years leading major efforts to combat HIV and AIDS throughout the world, is calling for global strategies and resources to confront the rapid "feminization" of the AIDS pandemic.

10 Jun 2005

Trade agreements 'bad medicine' for AIDS, says AIDS Healthcare Foundation

AIDS advocates from AIDS Healthcare Foundation (AHF), the nation's largest provider of HIV/AIDS medical care serving thousands of patients in the U.S., Africa, Central America and Asia, today hailed Representative Henry Waxman (D-CA) for his release of a new report detailing how the pending Central American Free Trade Agreement (CAFTA) and other trade agreements like NAFTA derail access to affordable generic medications in Latin and Central America and other developing world countries, including access to life-saving anti-retroviral therapies (ARVs) for HIV/AIDS treatment.

10 Jun 2005

Researchers discover how hepatic-C virus evades immune system in acute and chronic infections

Researchers at Johns Hopkins have uncovered how a majority of the genetic changes in the hepatic-C virus, the most common cause of liver disease, allow it to evade the body's immune system during infection.

10 Jun 2005